NeoGenomics
1 known investors
NeoGenomics develops diagnostic tests and tools for cancer care, including tests for immunotherapy response monitoring, therapy selection, and minimal residual disease detection.
Founders & leadership
TZ
Tony ZookinChief Executive Officer
Investors Β· 1
Frequently asked questions
- What does NeoGenomics do?
- NeoGenomics develops diagnostic tests and tools for cancer care, including tests for immunotherapy response monitoring, therapy selection, and minimal residual disease detection.
- Who are NeoGenomics's investors?
- NeoGenomics's investors include Ampersand.